Prophylactic efficacy of melatonin on cyclophosphamide-induced liver toxicity in mice

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Shokrzadeh, Mohammad ^a,b   Ahmadi, Amirhossein ^a   Naghshvar, Farshad ^b   Chabra, Aroona ^b   Jafarinejhad, Mehdi ^b  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; ENZYME; MELATONIN; ANTIOXIDANT; PROTECTIVE AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYCLOPHOSPHAMIDE INDUCED LIVER TOXICITY; DRUG EFFICACY; ENZYME BLOOD LEVEL; EXPERIMENTAL HEPATITIS; HISTOPATHOLOGY; LIVER PROTECTION; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; ANIMAL; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIPID PEROXIDATION; LIVER; OXIDATIVE STRESS; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; CYCLOPHOSPHAMIDE; DRUG-INDUCED LIVER INJURY; LIPID PEROXIDATION; LIVER; MELATONIN; MICE; OXIDATIVE STRESS; PROTECTIVE AGENTS;

EID: 84904736788     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/470425     Document Type: Article

References (38)

1. Dollery C., Therapeutic Drugs 1999 Edinburgh, UK Churchill Livingstone
2. Capel I. D., Jenner M., Dorrell H. M., Williams D. C., Hepatic function assessed (in rats) during chemotherapy with some anti-cancer drugs. Clinical Chemistry 1979 25 8 1381 1383 2-s2.0-0018648861 (Pubitemid 9247018)
3. Fraiser L. H., Kanekal S., Kehrer J. P., Cyclophosphamide toxicity: characterising and avoiding the problem. Drugs 1991 42 5 781 795 10.2165/00003495-199142050-00005 2-s2.0-0026411104 (Pubitemid 21920784)
4. Honjo I., Suou T., Hirayama C., Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis. Research Communications in Chemical Pathology and Pharmacology 1988 61 2 149 165 2-s2.0-0023786990
5. Bhattacharya A., Lawrence R. A., Krishnan A., Zaman K., Sun D., Fernandes G., Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice. Journal of the American College of Nutrition 2003 22 5 388 399 10.1080/07315724.2003.10719322 2-s2.0-0141919752 (Pubitemid 37254907)
6. Stankiewicz A., Skrzydlewska E., Makieła M., Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabolism and Drug Interactions 2002 19 2 67 82 2-s2.0-0037738907 (Pubitemid 36537996)
7. Weijl N. I., Cleton F. J., Osanto S., Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treatment Reviews 1997 23 4 209 240 10.1016/S0305-7372(97)90012-8 2-s2.0-0030684743 (Pubitemid 27464149)
8. Reiter R. J., Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review. Brazilian Journal of Medical and Biological Research 1993 26 11 1141 1155 2-s2.0-0027693553
9. Reiter R., Tang L., Garcia J. J., Muñoz-Hoyos A., Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sciences 1997 60 25 2255 2271 10.1016/S0024-3205(97)00030-1 2-s2.0-0030914428 (Pubitemid 27237237)
10. Cagnoli C. M., Atabay C., Kharlamova E., Manev H., Melatonin protects neurons from singlet oxygen-induced apoptosis. Journal of Pineal Research 1995 18 4 222 226 10.1111/j.1600-079X.1995.tb00163.x 2-s2.0-0029295723
11. Marshall K. A., Reiter R. J., Poeggeler B., Aruoma O. I., Halliwell B., Evaluation of the antioxidant activity of melatonin in vitro. Free Radical Biology and Medicine 1996 21 3 307 315 10.1016/0891-5849(96)00046-9 2-s2.0-1542312038 (Pubitemid 26271720)
12. Pieri C., Marra M., Moroni F., Recchioni R., Marcheselli F., Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sciences 1994 55 15 PL271 PL276 10.1016/0024-3205(94)00666-0 2-s2.0-0028137186 (Pubitemid 24290417)
13. Öner-Iyidogan Y., Gürdöl F., Öner P., The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes. Pharmacological Research 2001 44 2 89 93 10.1006/phrs.2001.0828 2-s2.0-0034917581 (Pubitemid 32695085)
14. Sewerynek E., Reiter R. J., Melchiorri D., Ortiz G. G., Lewinski A., Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepato-Gastroenterology 1996 43 10 898 905 2-s2.0-0029793307 (Pubitemid 26308371)
15. Chabra A., Shokrzadeh M., Naghshvar F., Salehi F., Ahmadi A., Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice. Human & Experimental Toxicology 2014 33 185 195
16. Karamian A., Shokrzadeh M., Ahmadi A., The potential chemoprotective effects of melatonin against genotoxicity induced by diazinon in human peripheral blood lymphocytes 2013 Toxicology and Industrial Health 10.1177/0748233713500824
17. Bhattacharjee R., Sil P. C., Protein isolate from the herb Phyllanthus niruri modulates carbon tetrachloride-induced cytotoxicity in hepatocytes. Toxicology Mechanisms and Methods 2006 17 1 41 47 10.1080/15376510600970034 2-s2.0-33845234243 (Pubitemid 44863781)
18. Ahmadi A., Ebrahimzadeh M. A., Ahmad-Ashrafi S., Karami M., Mahdavi M. R., Saravi S. S. S., Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists. Fundamental and Clinical Pharmacology 2011 25 1 72 79 10.1111/j.1472-8206.2009.00810.x 2-s2.0-78650944485
19. Khan T. S., Sundin A., Juhlin C., Wilander E., Öberg K., Eriksson B., Vincristine, cisplatin, teniposide, and cyclophosphamide combination in the treatment of recurrent or metastatic adrenocortical cancer. Medical Oncology 2004 21 2 167 177 10.1385/MO:21:2:167 2-s2.0-4243074009 (Pubitemid 39108007)
20. McDonald G. B., Slattery J. T., Bouvier M. E., Ren S., Batchelder A. L., Kalhorn T. F., Schoch H. G., Anasetti C., Gooley T., Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation. Blood 2003 101 5 2043 2048 10.1182/blood-2002-06-1860 2-s2.0-0037370735 (Pubitemid 36237612)
21. Patel J. M., Stimulation of cyclophosphamide-induced pulmonary microsomal lipid peroxidation by oxygen. Toxicology 1987 45 1 79 91 10.1016/0300-483X(87) 90116-8 2-s2.0-0023256366 (Pubitemid 17104563)
22. Ahmadi A., Hosseinimehr S. J., Naghshvar F., Hajir E., Ghahremani M., Chemoprotective effects of hesperidin against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Archives of Pharmacal Research 2008 31 6 794 797 10.1007/s12272-001-1228-z 2-s2.0-45749118021
23. Hosseinimehr S. J., Ahmadashrafi S., Naghshvar F., Ahmadi A., Ehasnalavi S., Tanha M., Chemoprotective effects of Zataria multiflora against genotoxicity induced by cyclophosphamide in mice bone marrow cells. Integrative Cancer Therapies 2010 9 2 219 223 10.1177/1534735409360361 2-s2.0-77954181335
24. Chabra A., Shokrzadeh M., Naghshvar F., Salehi F., Ahmadi A., Melatonin ameliorates oxidative stress and reproductive toxicity induced by cyclophosphamide in male mice. Human & Experimental Toxicology 2013 10.1177/0960327113489052
25. Das U. B., Mallick M., Debnath J. M., Ghosh D., Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorders in male rats. Asian Journal of Andrology 2002 4 3 201 207 2-s2.0-0036744865
26. Ghosh D., Das U. B., Ghosh S., Mallick M., Debnath J., Testicular gametogenic and steroidogenic activities in cyclophosphamide treated rat: a correlative study with testicular oxidative stress. Drug and Chemical Toxicology 2002 25 3 281 292 10.1081/DCT-120005891 2-s2.0-0035990685 (Pubitemid 34831279)
27. Habibi E., Shokrzadeh M., Ahmadi A., Chabra A., Naghshvar F., Keshavarz-Maleki R., Genoprotective effects of Origanum vulgare ethanolic extract against cyclophosphamide-induced genotoxicity in mice bone marrow cells. Pharmaceutical Biology 10.3109/13880209.2014.910674
28. Habibi E., Shokrzadeh M., Chabra A., Naghshvar F., Keshavarz-Maleki R., Ahmadi A., Protective effects of Origanum vulgare L. ethanolic extract against cyclophosphamide-induced liver toxicity in mice. Pharmaceutical Biology 10.3109/13880209.2014.908399
29. Shokrzadeh M., Ahmadi A., Chabra A., Naghshvar F., Salehi F., Habibi E., Haghi-Aminjan H., An ethanol extract of Origanum vulgare attenuates cyclophosphamide-induced pulmonary injury and oxidative lung damage in mice. Pharmaceutical Biology 2014 10.3109/13880209.2013.879908
30. Shokrzadeh M., Chabra A., Ahmadi A., Naghshvar F., Habibi E., Salehi F., Assadpour S., Hepatoprotective effects of Zataria multiflora ethanolic extract on liver toxicity induced by cyclophosphamide in mice. Drug Research 2014 10.1055/s-0034-1370932
31. Reiter R. J., Herman T. S., Meltz M. L., Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers. Mutation Research-Genetic Toxicology 1996 371 3-4 221 228 10.1016/S0165-1218(96)90110-X 2-s2.0-0030596153 (Pubitemid 27036284)
32. Shokrzadeh M., Chabra A., Naghshvar F., Ahmadi A., Jafarinejhad M., Hasani-Nourian Y., Protective effects of melatonin against cyclophosphamide- induced oxidative lung toxicity in mice. Drug Research 2014 10.1055/s-0034- 1371801
33. Elkiran T., Harputluoglu H., Yasar U., Babaoglu M. O., Dincel A. K., Altundag K., Ozisik Y., Guler N., Bozkurf A., Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients. Methods and Findings in Experimental and Clinical Pharmacology 2007 29 1 27 32 10.1358/mf.2007.29.1.1074690 2-s2.0-33947369020 (Pubitemid 46447220)
34. Selvakumar E., Prahalathan C., Mythili Y., Varalakshmi P., Mitigation of oxidative stress in cyclophosphamide-challenged hepatic tissue by DL- lipoic acid. Molecular and Cellular Biochemistry 2005 272 1-2 179 185 10.1007/s11010-005-7322-4 2-s2.0-20944439997 (Pubitemid 40867379)
35. Mathew S., Kuttan G., Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. Journal of Experimental & Clinical Cancer Research 1997 16 4 407 411 2-s2.0-0031422883 (Pubitemid 28083542)
36. Sulkowska M., Sulkowski S., Skrzydlewska E., The effect of pentoxifylline on ultrastructure and antioxidant potential during cyclophosphamide-induced liver injury. Journal of Submicroscopic Cytology and Pathology 1999 31 3 413 422 2-s2.0-0033155309 (Pubitemid 129553517)
37. McDonald G. B., Frieze D., A problem-oriented approach to liver disease in oncology patients. Gut 2008 57 7 987 1003 10.1136/gut.2007.131136 2-s2.0-46349095830 (Pubitemid 351919535)
38. Senthilkumar S., Devaki T., Manohar B. M., Babu M. S., Effect of squalene on cyclophosphamide-induced toxicity. Clinica Chimica Acta 2006 364 1-2 335 342 10.1016/j.cca.2005.07.032 2-s2.0-31044456008 (Pubitemid 43120664)